ClinicalTrials.gg
RecruitingNCT07393971Updated Nov 6, 2026

Development of a Real-time Controller to Estimate Walking Performance Using a Bilateral Ankle Exoskeleton

An interventional study of Adaptive Torque Control System for Ankle Exoskeleton in Healthy Young Adults, sponsored by University of Nebraska. Recruiting at 1 site in United States. Open to participants aged 19 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by University of Nebraska · Not applicable, Interventional, and Device feasibility

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Updated Nov 6, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
6
Allocation
Not applicable
Ages
19 Years to 35 Years
Sex
All
01

Study summary

This study is developing and testing a new controller for a robotic ankle exoskeleton (Biomotum) that can adjust itself in real time to better support people while they walk. The system learns how each person moves and automatically changes the amount and timing of assistance to make walking feel easier and more efficient. By using information from the person wearing the device, the exoskeleton can quickly find the level of support that works best for them. The long-term goal is to create personalized walking assistance that can help people with mobility limitations move more comfortably and with less effort.

Read the detailed description

This project aims to develop and test a real-time adaptive controller for a robotic ankle exoskeleton (Biomotum) that personalizes assistance to each user by minimizing metabolic cost and optimizing muscle activation patterns during walking. Using human-in-the-loop optimization and advanced musculoskeletal modeling, the controller will dynamically adjust torque magnitude and timing to achieve optimal performance more quickly than current methods.

02

Conditions studied

  • Healthy Young Adults

Keywords

  • robotic ankle exoskeleton
  • human-in-the-loop optimization
  • wearable robotics
  • musculoskeletal modeling
  • muscle activation analysis
03

In context

Lead sponsor

University of Nebraska is the lead sponsor of 496 studies on the registry; 66 are open to participants now.

Of its 83 completed or terminated interventional studies of FDA-regulated products, 53 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • able to walk independently on a treadmill for 10 minutes,
  • free of neurological, cardiovascular, pulmonary, or musculoskeletal conditions that limit walking and exercising,
  • no current lower extremity pain or injury,
  • able to wear an exoskeleton and safety harness, can provide

Exclusion criteria

Exclusion Criteria:

  • history of neurological disease that affected gait or balance,
  • current or recent lower extremity musculoskeletal injury or surgery,
  • chronic lower extremity pain during walking,
  • inability to participate in moderate-intensity exercise,
  • require an assistive device for walking,
  • any metabolic or systemic diseases that may be exacerbated by exercise
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
6 participants (estimated)

Study arms

  • Experimental
    Single-Arm Study of a Personalized Robotic Ankle Exoskeleton Controller

    This arm employs a within-subject design with two methods of estimating metabolic cost versus the gold standard measure of metabolic cost, wherein a single participant is subjected to two distinct measurements. This design allows for a direct comparison of the effects of each method (i.e., estimation versus gold standard) within the same individual, minimizing intersubject variability and enhancing the statistical power of the analysis.

    Device: Adaptive Torque Control System for Ankle Exoskeleton

Interventions

  • DeviceAdaptive Torque Control System for Ankle Exoskeleton

    This intervention uses a robotic ankle exoskeleton equipped with a real-time adaptive controller that adjusts plantarflexion torque based on each participant's walking mechanics. Unlike standard exoskeleton controllers that use fixed or pre-programmed assistance levels, this system employs human-in-the-loop optimization to continuously update torque magnitude and timing during treadmill walking. The controller integrates metabolic estimations, kinematic data, and musculoskeletal modeling to identify individualized assistance patterns that reduce walking effort and improve muscle activation efficiency. Participants complete multiple walking trials while the controller automatically modifies assistance to determine the optimal personalized settings.

06

What researchers measure

Primary outcomes

  1. Successful Real-Time Operation of the Robotic Ankle Exoskeleton Controller

    Device feasibility will be evaluated by the successful real-time operation of the robotic ankle exoskeleton and adaptive controller during treadmill walking. Feasibility is defined as the controller's ability to continuously generate, update, and apply assistive torque in real time based on incoming biomechanical and physiological data without system failure, interruption, or safety-related termination. Successful operation will be confirmed by continuous controller function and synchronized data acquisition across walking trials.

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. Net Metabolic Rate During Exoskeleton-Assisted Walking Measured by Indirect Calorimetry

    Net oxygen consumption (VO₂) and carbon dioxide production (VCO₂) will be measured during treadmill walking using indirect calorimetry (Cosmed K5, Cosmed USA Inc., Chicago, IL). Metabolic rate will be calculated using standard equations during steady-state walking conditions. Measurements will be collected at regular intervals to characterize metabolic demand under different exoskeleton assistance configurations.

    Time frame: through study completion, an average of 1 year

  2. Estimated Metabolic Rate Derived From Joint-Space Musculoskeletal Modeling

    Estimated metabolic rate will be derived from joint-space musculoskeletal models using kinematic and kinetic data collected during treadmill walking. Model-based estimates will be computed on a stride-by-stride basis to provide an indirect estimate of metabolic demand that can be compared with direct measurements from indirect calorimetry.

    Time frame: through study completion, an average of 1 year

  3. Estimated Lower-Limb Muscle Activation Derived From Joint-Space Musculoskeletal Modeling

    Lower-limb muscle activation patterns will be estimated using joint-space musculoskeletal models based on motion capture and ground reaction force data collected during treadmill walking. Estimated muscle activation values will be computed on a stride-by-stride basis to characterize neuromuscular engagement during exoskeleton-assisted gait.

    Time frame: through study completion, an average of 1 year

  4. Lower-Limb Muscle Activation Measured by Surface Electromyography During Walking

    Muscle activation of lower-limb muscles (e.g., tibialis anterior, gastrocnemius medialis, gastrocnemius lateralis, soleus) will be measured during treadmill walking using surface electromyography (Delsys). EMG signals will be collected continuously and processed to quantify muscle activation patterns during exoskeleton-assisted gait.

    Time frame: through study completion, an average of 1 year

  5. During treadmill walking trials conducted at a single study visit

    Controller parameter convergence will be assessed during human-in-the-loop optimization trials by evaluating changes in controller gain and timing parameters across successive walking bouts. Convergence is defined as stabilization of controller parameters within a predefined range during the optimization process.

    Time frame: through study completion, an average of 1 year

07

Study locations

1 of 1 sites recruiting
  • Biomechanics Research Building, University of Nebraska at Omaha
    Omaha, Nebraska 68108, United States
    Recruiting
    • Farah Fallahtafti, PhD · Contactffallahtafti@unomaha.edu · 4025543075
    • Sara Myers, PhD · Contactsamyers@unomaha.edu · 4025543246
    • Farah Fallahtafti, PhD · Principal investigator
    • Arash Gonabadi, PhD · Sub investigator
    • Sara Myers, PhD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — IPD will not be shared because direct measurements are only taken for baseline measurements that the modeling software will be using. The scripts and code used will be shared through opensource, but that does not include subject data.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Aug 2026 (actual). Primary completion is estimated for Aug 2028, 24 months after the start.

Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Aug 2026, on Nov 6, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 5, 2025
First posted
Feb 6, 2026
StartActual
Aug 15, 2026was Sep 2026
Primary completionEst.
Aug 2028
CompletionEst.
Dec 2028
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 6, 2026
Sites
Biomechanics Research Building, University of Nebraska at Omaha is now Recruiting
Nov 6, 2026
Start date
Sep 1, 2026→Aug 15, 2026 (actual)
Nov 6, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Biomechanics Research Building, University of Nebraska at Omaha · Omaha, United StatesContact added f•••@unomaha.edu · •••3075Contact added s•••@unomaha.edu · •••3246Contact added (no phone or email listed)Contact added (no phone or email listed)Contact added (no phone or email listed)
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Not yet recruiting→Recruiting
    Biomechanics Research Building, University of Nebraska at Omaha is now Recruiting
    Start date Sep 1, 2026→Aug 15, 2026 (now actual)
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Biomechanics Research Building, University of Nebraska at Omaha · Omaha, United StatesContact added f•••@unomaha.edu · •••3075Contact added s•••@unomaha.edu · •••3246Contact added (no phone or email listed)Contact added (no phone or email listed)Contact added (no phone or email listed)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07393971
Collaborators
Madonna Rehabilitation Hospital
Responsible party
Sponsor
First posted
Feb 6, 2026
Start date
Aug 15, 2026
Primary completion
Aug 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Nov 6, 2026

Study contacts

Farah Fallahtafi, PhD
Contact
ffallahtafti@unomaha.edu
4025543075
Farah Fallahtafti, PhD
principal investigator · Department of Biomechanics, University of Nebraska at Omaha

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion